Genetic Obesity Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Genetic Obesity Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genetic Obesity Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Obesity Drug Overall Market Size
2.1 Global Genetic Obesity Drug Market Size: 2022 VS 2029
2.2 Global Genetic Obesity Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genetic Obesity Drug Players in Global Market
3.2 Top Global Genetic Obesity Drug Companies Ranked by Revenue
3.3 Global Genetic Obesity Drug Revenue by Companies
3.4 Top 3 and Top 5 Genetic Obesity Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genetic Obesity Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genetic Obesity Drug Players in Global Market
3.6.1 List of Global Tier 1 Genetic Obesity Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Genetic Obesity Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genetic Obesity Drug Market Size Markets, 2022 & 2029
4.1.2 Sibutramine
4.1.3 Orlistat
4.1.4 Sympathomimetic Drugs
4.1.5 Receptors Antagonists
4.1.6 Others
4.2 By Type - Global Genetic Obesity Drug Revenue & Forecasts
4.2.1 By Type - Global Genetic Obesity Drug Revenue, 2018-2023
4.2.2 By Type - Global Genetic Obesity Drug Revenue, 2024-2029
4.2.3 By Type - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetic Obesity Drug Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Genetic Obesity Drug Revenue & Forecasts
5.2.1 By Application - Global Genetic Obesity Drug Revenue, 2018-2023
5.2.2 By Application - Global Genetic Obesity Drug Revenue, 2024-2029
5.2.3 By Application - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Genetic Obesity Drug Market Size, 2022 & 2029
6.2 By Region - Global Genetic Obesity Drug Revenue & Forecasts
6.2.1 By Region - Global Genetic Obesity Drug Revenue, 2018-2023
6.2.2 By Region - Global Genetic Obesity Drug Revenue, 2024-2029
6.2.3 By Region - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Genetic Obesity Drug Revenue, 2018-2029
6.3.2 US Genetic Obesity Drug Market Size, 2018-2029
6.3.3 Canada Genetic Obesity Drug Market Size, 2018-2029
6.3.4 Mexico Genetic Obesity Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Genetic Obesity Drug Revenue, 2018-2029
6.4.2 Germany Genetic Obesity Drug Market Size, 2018-2029
6.4.3 France Genetic Obesity Drug Market Size, 2018-2029
6.4.4 U.K. Genetic Obesity Drug Market Size, 2018-2029
6.4.5 Italy Genetic Obesity Drug Market Size, 2018-2029
6.4.6 Russia Genetic Obesity Drug Market Size, 2018-2029
6.4.7 Nordic Countries Genetic Obesity Drug Market Size, 2018-2029
6.4.8 Benelux Genetic Obesity Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Genetic Obesity Drug Revenue, 2018-2029
6.5.2 China Genetic Obesity Drug Market Size, 2018-2029
6.5.3 Japan Genetic Obesity Drug Market Size, 2018-2029
6.5.4 South Korea Genetic Obesity Drug Market Size, 2018-2029
6.5.5 Southeast Asia Genetic Obesity Drug Market Size, 2018-2029
6.5.6 India Genetic Obesity Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Genetic Obesity Drug Revenue, 2018-2029
6.6.2 Brazil Genetic Obesity Drug Market Size, 2018-2029
6.6.3 Argentina Genetic Obesity Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genetic Obesity Drug Revenue, 2018-2029
6.7.2 Turkey Genetic Obesity Drug Market Size, 2018-2029
6.7.3 Israel Genetic Obesity Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Genetic Obesity Drug Market Size, 2018-2029
6.7.5 UAE Genetic Obesity Drug Market Size, 2018-2029
7 Genetic Obesity Drug Companies Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Genetic Obesity Drug Major Product Offerings
7.1.4 Pfizer, Inc. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.1.5 Pfizer, Inc. Key News & Latest Developments
7.2 Sanofi.
7.2.1 Sanofi. Company Summary
7.2.2 Sanofi. Business Overview
7.2.3 Sanofi. Genetic Obesity Drug Major Product Offerings
7.2.4 Sanofi. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.2.5 Sanofi. Key News & Latest Developments
7.3 Tonghua Dongbao Pharmaceutical Co., Ltd.
7.3.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Company Summary
7.3.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Business Overview
7.3.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Major Product Offerings
7.3.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.3.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Biocon.
7.4.1 Biocon. Company Summary
7.4.2 Biocon. Business Overview
7.4.3 Biocon. Genetic Obesity Drug Major Product Offerings
7.4.4 Biocon. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.4.5 Biocon. Key News & Latest Developments
7.5 Adocia
7.5.1 Adocia Company Summary
7.5.2 Adocia Business Overview
7.5.3 Adocia Genetic Obesity Drug Major Product Offerings
7.5.4 Adocia Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.5.5 Adocia Key News & Latest Developments
7.6 GlaxoSmithKline Plc.
7.6.1 GlaxoSmithKline Plc. Company Summary
7.6.2 GlaxoSmithKline Plc. Business Overview
7.6.3 GlaxoSmithKline Plc. Genetic Obesity Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.7 Novo Nordisk A/S.
7.7.1 Novo Nordisk A/S. Company Summary
7.7.2 Novo Nordisk A/S. Business Overview
7.7.3 Novo Nordisk A/S. Genetic Obesity Drug Major Product Offerings
7.7.4 Novo Nordisk A/S. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk A/S. Key News & Latest Developments
7.8 Oramed Pharmaceuticals, Inc
7.8.1 Oramed Pharmaceuticals, Inc Company Summary
7.8.2 Oramed Pharmaceuticals, Inc Business Overview
7.8.3 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Major Product Offerings
7.8.4 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.8.5 Oramed Pharmaceuticals, Inc Key News & Latest Developments
7.9 Wockhardt.
7.9.1 Wockhardt. Company Summary
7.9.2 Wockhardt. Business Overview
7.9.3 Wockhardt. Genetic Obesity Drug Major Product Offerings
7.9.4 Wockhardt. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.9.5 Wockhardt. Key News & Latest Developments
7.10 Eli Lilly and Company.
7.10.1 Eli Lilly and Company. Company Summary
7.10.2 Eli Lilly and Company. Business Overview
7.10.3 Eli Lilly and Company. Genetic Obesity Drug Major Product Offerings
7.10.4 Eli Lilly and Company. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly and Company. Key News & Latest Developments
7.11 Merck & Co., Inc.
7.11.1 Merck & Co., Inc. Company Summary
7.11.2 Merck & Co., Inc. Business Overview
7.11.3 Merck & Co., Inc. Genetic Obesity Drug Major Product Offerings
7.11.4 Merck & Co., Inc. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.11.5 Merck & Co., Inc. Key News & Latest Developments
7.12 Julphar.
7.12.1 Julphar. Company Summary
7.12.2 Julphar. Business Overview
7.12.3 Julphar. Genetic Obesity Drug Major Product Offerings
7.12.4 Julphar. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.12.5 Julphar. Key News & Latest Developments
7.13 Bristol-Myers Squibb Company.
7.13.1 Bristol-Myers Squibb Company. Company Summary
7.13.2 Bristol-Myers Squibb Company. Business Overview
7.13.3 Bristol-Myers Squibb Company. Genetic Obesity Drug Major Product Offerings
7.13.4 Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue in Global Market (2018-2023)
7.13.5 Bristol-Myers Squibb Company. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Genetic Obesity Drug Market Opportunities & Trends in Global Market
Table 2. Genetic Obesity Drug Market Drivers in Global Market
Table 3. Genetic Obesity Drug Market Restraints in Global Market
Table 4. Key Players of Genetic Obesity Drug in Global Market
Table 5. Top Genetic Obesity Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Genetic Obesity Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Genetic Obesity Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Genetic Obesity Drug Product Type
Table 9. List of Global Tier 1 Genetic Obesity Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Obesity Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Genetic Obesity Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Genetic Obesity Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Genetic Obesity Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Genetic Obesity Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Genetic Obesity Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Genetic Obesity Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Genetic Obesity Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Genetic Obesity Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Genetic Obesity Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Genetic Obesity Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Genetic Obesity Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Genetic Obesity Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Genetic Obesity Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Genetic Obesity Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Genetic Obesity Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Genetic Obesity Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Genetic Obesity Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Genetic Obesity Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Genetic Obesity Drug Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer, Inc. Company Summary
Table 31. Pfizer, Inc. Genetic Obesity Drug Product Offerings
Table 32. Pfizer, Inc. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer, Inc. Key News & Latest Developments
Table 34. Sanofi. Company Summary
Table 35. Sanofi. Genetic Obesity Drug Product Offerings
Table 36. Sanofi. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi. Key News & Latest Developments
Table 38. Tonghua Dongbao Pharmaceutical Co., Ltd. Company Summary
Table 39. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Product Offerings
Table 40. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Tonghua Dongbao Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 42. Biocon. Company Summary
Table 43. Biocon. Genetic Obesity Drug Product Offerings
Table 44. Biocon. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Biocon. Key News & Latest Developments
Table 46. Adocia Company Summary
Table 47. Adocia Genetic Obesity Drug Product Offerings
Table 48. Adocia Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Adocia Key News & Latest Developments
Table 50. GlaxoSmithKline Plc. Company Summary
Table 51. GlaxoSmithKline Plc. Genetic Obesity Drug Product Offerings
Table 52. GlaxoSmithKline Plc. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline Plc. Key News & Latest Developments
Table 54. Novo Nordisk A/S. Company Summary
Table 55. Novo Nordisk A/S. Genetic Obesity Drug Product Offerings
Table 56. Novo Nordisk A/S. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Novo Nordisk A/S. Key News & Latest Developments
Table 58. Oramed Pharmaceuticals, Inc Company Summary
Table 59. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Product Offerings
Table 60. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Oramed Pharmaceuticals, Inc Key News & Latest Developments
Table 62. Wockhardt. Company Summary
Table 63. Wockhardt. Genetic Obesity Drug Product Offerings
Table 64. Wockhardt. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Wockhardt. Key News & Latest Developments
Table 66. Eli Lilly and Company. Company Summary
Table 67. Eli Lilly and Company. Genetic Obesity Drug Product Offerings
Table 68. Eli Lilly and Company. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lilly and Company. Key News & Latest Developments
Table 70. Merck & Co., Inc. Company Summary
Table 71. Merck & Co., Inc. Genetic Obesity Drug Product Offerings
Table 72. Merck & Co., Inc. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Merck & Co., Inc. Key News & Latest Developments
Table 74. Julphar. Company Summary
Table 75. Julphar. Genetic Obesity Drug Product Offerings
Table 76. Julphar. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Julphar. Key News & Latest Developments
Table 78. Bristol-Myers Squibb Company. Company Summary
Table 79. Bristol-Myers Squibb Company. Genetic Obesity Drug Product Offerings
Table 80. Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Bristol-Myers Squibb Company. Key News & Latest Developments
List of Figures
Figure 1. Genetic Obesity Drug Segment by Type in 2022
Figure 2. Genetic Obesity Drug Segment by Application in 2022
Figure 3. Global Genetic Obesity Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genetic Obesity Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genetic Obesity Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genetic Obesity Drug Revenue in 2022
Figure 8. By Type - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Genetic Obesity Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Genetic Obesity Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 16. US Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 20. Germany Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 28. China Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Genetic Obesity Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Genetic Obesity Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer, Inc. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biocon. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Adocia Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline Plc. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novo Nordisk A/S. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Wockhardt. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lilly and Company. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck & Co., Inc. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Julphar. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
